FDA Approved: GABAPENTIN — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for gabapentin from Actavis Pharma, Inc. under ANDA075350, typically reflecting a label change or formulation update for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Postherpetic Neuralgia

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

SUPPL AP for GABAPENTIN (GABAPENTIN)